Method for enriching tumor infiltrating lymphocytes
AssigneeAbelzeta Inc.
InventorsXiaobing LUO, Fei TANG, Michael PATRICK, Thu Le TRINH, Jiaqi HUANG, Xin YAO, Shigui ZHU, Yihong YAO
Life of this patent
Estimating the term…
Abstract
The present disclosure provides for improved methods for expanding tumor infiltrating lymphocytes (TILs) and producing therapeutic populations of TILs in a shorter time period than the traditional methods. TIL cell therapy products can be manufactured which easily meet the target cell dose while maintaining desired T cell phenotype.
Claims32
A method of expanding tumor-infiltrating lymphocytes (TILs), the method comprising:
- (a) culturing a first population of cells in a first cell culture medium to generate a second population of cells, wherein the first population of cells is obtained from a tumor sample from a patient;
- and
- (b) contacting the second population of cells with a polymeric matrix comprising anti-CD3 and anti-CD28 antibodies or fragments thereof in a second cell culture medium, to generate a third population of cells, wherein the second cell culture medium comprises about 100 IU/mL to about 8,000 IU/mL interleukin-2 (IL-2).
6-7. (canceled)
(canceled)
(canceled)
A cell population enriched for, or expanded from, tumor-infiltrating lymphocytes, comprising one or more of the following:
- (i) CD3+ CD8+ T cells at a percentage ranging from about 3% to about 88% of CD3+ cells,
- (ii) CD3+ CD4+ T cells at a percentage ranging from about 10% to about 96% of CD3+ cells,
- (iii) CD4+ TCM T cells at a percentage ranging from about 50% to about 88% of CD4+ cells,
- (iv) CD8+ TCM T cells at a percentage ranging from about 28% to about 82% of CD8+ cells,
- (v) CD4+ TEM T cells at a percentage ranging from about 11% to about 49% of CD4+ cells, and
- (vi) CD8+ TEM T cells at a percentage ranging from about 11% to about 61% of CD8+ cells, wherein the cell population comprises no less than 70% of live cells, and wherein the cell population is generated from a tumor sample from a patient.
(canceled)
A method of expanding a cell population enriched for tumor-infiltrating lymphocytes, the method comprising:
- (a) culturing cells obtained from a tumor sample from a patient;
- (b) treating the cultured cells to generate a cell population enriched for tumor-infiltrating lymphocytes, the cell population comprising one or more of the following:
- (i) CD3+ CD8+ T cells at a percentage ranging from about 3% to about 88% of CD3+ cells,
- (ii) CD3+ CD4+ T cells at a percentage ranging from about 10% to about 96% of CD3+ cells,
- (iii) CD4+ CD45RA−CD62L+ central memory T cells at a percentage ranging from about 50% to about 88% of CD4+ cells,
- (iv) CD8+CD45RA−CD62L+ central memory T cells at a percentage ranging from about 28% to about 82% of CD8+ cells,
- (v) CD4+CD45RA−CD62L− effector memory T cells at a percentage ranging from about 11% to about 49% of CD4+ cells, and
- (vi) CD8+ T CD45RA−CD62L− effector memory T cells at a percentage ranging from about 11% to about 61% of CD8+ cells.
29-33. (canceled)
(canceled)
37-38. (canceled)
Dependencies are inferred from the claim text.